Skip to main content
. 2015 Sep 17;6(9):e1890. doi: 10.1038/cddis.2015.232

Figure 4.

Figure 4

C2-ceramide-mediated SGK-1 expression is activated via p38/MAPK, cAMP/PKA and PI3K pathways. HEK-293 cells stably transfected with SGK-1wt were treated with C2-ceramide (50 μM), C2-Dihy (50 μM), SB202190 (10 μM) (p38 inhibitor), H-89 (10 μM) (PKA inhibitor) and LY294002 (30 μM) (PI3K inhibitor). After 48 h, SGK-1 expression was evaluated with antibodies specific for SGK-1. The protein levels of SGK-1 were compared with Tubulin levels. Results were confirmed in at least three separate experiments. Blots shown are representative of three independent experiments. Tubulin was used as a loading control (a). A quantification of three independent experiments by scanning densitometry is shown in (b) (*P<0.05, **P<0.01; N=3). The Ratio between C2-ceramide (C2) and C2-Dihy or C2-ceramide with inhibitors (C2/C2SB, C2/C2H89, C2/C2LY) was evaluated (c), *P<0.05, C2/C2-Dihy versus C2/C2SB, C2/C2H89; N=3. Results are expressed as means±S.D.